group 21 to 25 Flashcards
what is immunovant
clinical stage immunology company
what is immunovant platform
targeted monoclonal antibodies
what is acelyrin
late stage clinical biopharma company
what does acelyrin do
identifying, aquiring and accekerating the development and commercialization of medecines for diseases related to excess activation of the immune system
what is apogee
clinical stage biotech
what is apogee therapeutics platform
engineered monoclonal antibodies (mAbs) with potential best-in-class profiles to overcome current therapy limitations by optimizing
half-life, maximizing antibody recycling, and decreasing the dosing for patients.
what is tourmaline
late stage clinical biotech
what is tourmaline platform
focused on developing drugs to improve immune and inflammatoty diseases to set up new standards care for unmet medical needs
what is vir biotech
makes antiviral treatmnets
what is the platform of vur biotech
-Monoclonal antibody platform with AI-led protein engineering capabilities
○ T cell-based viral vector platform (Induce T cell response with engineered HCMV)
○ siRNA (in combination with antibodies)
what is atea pharmaceuticals
clinical stage biotech company commited to the discovert, development and commercialization of orally availabel direct acting antiviral therapies
what is the atea platform
Nucleus(t)ide analogs and prodrugs targeting RNA-dependent RNA polymerase of
+ssRNA viruses (mainly COVID-19, HCV, Dengue but were previously working on an RSV
drug).
what is regeron
Leading biotechnology company founded and led by physician-scientists whose medicines and pipelines are designed to
treat a variety of serious diseases such as eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and
metabolic diseases, hematologic conditions, infectious diseases, and rare diseases
what is regeneron platform
fully human therapeutoc antibodies and bispecific antibodies aka velocisuite tech
what is anapsdybio
o is a clinical-stage biotechnology company working to transform patient health by delivering innovative
immunology therapeutics with a focus on addressing unmet medical needs in autoimmune and inflammatory diseases.
what is anaptysbio platform
Coupling mammalian cell surface display with somatic hypermutation (SHM) for the discovery and maturation of
human antibodies
what is ovid therapeutics
clinical stage biopharmaceutical comp
what is ovid theraoeutics platform
small molecules trating the symtoms of epilepsy and other cns disorders
what is wave life sciences
s a biotechnology company which pioneers in transformative RNA medicines
what is wave life sciences platform
PRISMTM is an oligonucleotide platform combining four RNA-targeting modalities (editing, splicing, siRNA and antisense).
what is denali therapeutics
Clinical-stage biopharmaceutical company focusing on treatment of neurodegenerative
and lysosomal storage diseases.
what is the platform of debali therapeutics
Proprietary antibody transport vehicles (ATVs) and enzyme transport
vehicles (ETVs) with engineered BBB receptor binding into an Fc domain (Transferrin
receptor, TfR, highly expressed) thus actively transporting molecules across the BBB
through receptor-mediated transcytosis (RMT).
what is pic therapeutics
clinical stage biopharmaceutica company
what is pic therapeutics platfoem
small molecules that modify splicing, ferroptosis and inflammation
what is agios pharmaceutical platform
Mitapivat - first-in-class oral small molecule acts as an allosteric activator for the Pyruvate kinase (PK) enzyme, enhancing its
function. By binding allosterically, it boosts enzyme activity, leading to increased ATP production and reduced 2,3-diphosphoglycerate
levels. Consequently, this results in an extended lifespan for red blood cells (RBCs).
what is keros therapeutics
clinical stahe biopharma
what is the platform of keros
Main focus on leveraging protein engineering, specifically working on the transforming growth factor-beta (TGF-β) superfamily to
develop large and small molecule treatments. Use a proprietary library of ActRII Ligand traps.
what is beam therapeutics
clinical stage biopharmaceutical
what is beam therapeutics platform
Pioneering precision genetic medicine via gene editing/delivery technologies to address unmet medical needs for patients affected by Sickle Cell Disease
(SCD), T-Cell Cancers, Glycogen Storage Disease 1a (GSD1a), Alpha-1 Antitrypsin Deficiency (AATD) & other rare and serious diseases
what is editas medecine platform
CRISPR - “Clustered, Regularly Interspaced, Short Palindromic Repeats,” can edit nearly any location in the genome in any cell or tissue, highly specific
○ Use two different proprietary CRISPR nucleases: SaCas9 and AsCas12a
what is arvinas
preclinical biotech